Insider Trading February 13, 2026

P&G Executive Chairman Disposes of 173,268 Shares, Exercises Options in Same Transaction

Jon R. Moeller sold $28.1 million of stock and exercised options while Procter & Gamble posts mixed fiscal Q2 results and draws analyst upgrades

By Priya Menon PG
P&G Executive Chairman Disposes of 173,268 Shares, Exercises Options in Same Transaction
PG

Jon R. Moeller, Executive Chairman of Procter & Gamble Co., sold 173,268 shares on February 11 and 12, 2026, generating $28.1 million in proceeds and concurrently exercised options to acquire the same number of shares at $113.23 per share for $19.6 million. The company reported fiscal second-quarter 2026 results with EPS of $1.88 versus consensus $1.86 and revenue of $22.2 billion versus expected $22.34 billion. Several Wall Street firms raised price targets and ratings following the report.

Key Points

  • Jon R. Moeller sold 173,268 Procter & Gamble shares on February 11 and 12, 2026, totaling $28.1 million in proceeds.
  • Moeller simultaneously exercised options to acquire 173,268 shares at $113.23 per share for a total of $19.6 million; he now directly holds 319,384.99 shares.
  • Procter & Gamble reported fiscal Q2 2026 EPS of $1.88 (consensus $1.86) and revenue of $22.2 billion (consensus $22.34 billion); multiple analysts raised price targets and ratings.

Executive chairman transacts large share sale and option exercise

Jon R. Moeller, serving as Executive Chairman of the Board at Procter & Gamble Co., executed a sizable equity transaction over two days in February 2026. On February 11 and 12, 2026, Moeller sold a total of 173,268 shares of Procter & Gamble common stock, generating aggregate proceeds of $28.1 million. The sale included a trade at $160.00 on February 11 and additional sales on February 12 at a weighted average price of $162.4486, with individual prices on that day ranging from $162.13 to $162.65.

Concurrently, Moeller exercised stock options to acquire 173,268 shares of Procter & Gamble common stock at an exercise price of $113.23 per share on the same dates. The total value associated with those option exercises is $19.6 million.


Post-transaction ownership snapshot

After completing the sale and the option exercises, Moeller directly holds 319,384.99 shares of Procter & Gamble. In addition to his direct holdings, the filings show indirect ownership positions of 25,001.0511 shares held by Retirement Plan Trustees and 35,421.5707 shares held by his spouse.


Company results and analyst reactions

Procter & Gamble reported fiscal second-quarter results for 2026 that showed a modest beat on earnings per share and a shortfall on revenue. The company posted EPS of $1.88, slightly above the consensus estimate of $1.86. Revenue for the quarter was reported at $22.2 billion, which fell short of the consensus projection of $22.34 billion.

Following the release of the results, several research firms adjusted their views and price targets. UBS raised its price target to $170 and maintained a Buy rating. Wells Fargo moved its target to $165 while keeping an Overweight rating. BofA Securities increased its price target to $171, citing the company’s reiteration of its full-year guidance and maintained a Buy rating. JPMorgan upgraded Procter & Gamble from Neutral to Overweight and set a price target of $165, pointing to optimism about potential for improved organic sales growth and margin enhancements. These analyst actions collectively reflect a constructive outlook among those firms despite mixed quarterly results.


Takeaway

The filings document a coordinated set of transactions by the executive chairman that combined option exercises with stock sales, while the company delivered mixed financial results and received a series of positive analyst updates. The public record shows the precise amounts, prices, and ownership positions described above.


Summary

Jon R. Moeller sold 173,268 Procter & Gamble shares on February 11-12, 2026 for $28.1 million, exercised options to acquire the same number of shares at $113.23 per share for $19.6 million, and now directly owns 319,384.99 shares. Procter & Gamble reported fiscal Q2 EPS of $1.88 on $22.2 billion in revenue; several analysts subsequently raised price targets and ratings.

Risks

  • Revenue for Procter & Gamble’s fiscal Q2 2026 fell short of expectations at $22.2 billion versus the anticipated $22.34 billion, highlighting potential top-line pressure in consumer products.
  • The insider sale, while paired with option exercises, represents a material change in near-term shareholding for the executive chairman and could be interpreted variably by markets.
  • Analyst optimism reflected in higher price targets is contingent on improved organic sales growth and margin enhancements, outcomes which are not guaranteed by the current quarter’s mixed results.

More from Insider Trading

Clean Harbors Director Executes $204,802 Sale as Company Reports Strong Q4 and Pushes M&A Agenda Feb 21, 2026 Clean Harbors Executive Disposes Nearly $1.0M in Stock as Company Posts Strong Q4 Feb 21, 2026 Clean Harbors CFO Disposes $784K in Shares as Company Reports Strong Quarter and Pursues Acquisition Feb 21, 2026 Travelers Executive Vice President Records $1.74 Million Share Sale as Company Posts Strong Quarter Feb 21, 2026 Genasys Director Buys $50,404 of Stock; Company Reports Mixed Q1 Results Feb 21, 2026